We are live on ! Find out more
TFCP

Twin Focus Capital Partners Portfolio holdings

AUM $983M
1-Year Est. Return 37.07%
This Fund
S&P 500
This Quarter Est. Return
+5.14%
1 Year Est. Return
+37.07%
3 Year Est. Return
+92.46%
5 Year Est. Return
+88%
10 Year Est. Return
+241.11%
AUM
$350M
AUM Growth
+$23.2M
Cap. Flow
+$7.42M
Cap. Flow %
2.12%
Top 10 Hldgs %
47.09%
Holding
178
New
15
Increased
51
Reduced
33
Closed
17
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXN icon
126
Texas Instruments
TXN
$261B
$265K 0.08%
1,402
+8
+0.6% +$1.39K
NOBL icon
127
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$257K 0.07%
5,964
MS icon
128
Morgan Stanley
MS
$340B
$256K 0.07%
3,301
+90
+3% +$6.9K
MOO icon
129
VanEck Agribusiness ETF
MOO
$973M
$246K 0.07%
2,800
MDT icon
130
Medtronic
MDT
$112B
$245K 0.07%
2,075
+5
+0.2% +$586
VPL icon
131
Vanguard FTSE Pacific ETF
VPL
$8.44B
$245K 0.07%
3,000
HD icon
132
Home Depot
HD
$355B
$242K 0.07%
794
EFA icon
133
iShares MSCI EAFE ETF
EFA
$80.2B
$240K 0.07%
3,158
VIGI icon
134
Vanguard International Dividend Appreciation ETF
VIGI
$9.31B
$232K 0.07%
+2,800
New +$233K
VRTX icon
135
Vertex Pharmaceuticals
VRTX
$126B
$230K 0.07%
1,072
+52
+5% +$11.4K
KBE icon
136
State Street SPDR S&P Bank ETF
KBE
$1.71B
$226K 0.06%
+4,350
New +$212K
AIG icon
137
American International
AIG
$41.3B
$224K 0.06%
+4,839
New +$209K
UNH icon
138
UnitedHealth
UNH
$370B
$224K 0.06%
603
UNP icon
139
Union Pacific
UNP
$174B
$224K 0.06%
1,015
+3
+0.3% +$630
HERZ
140
Herzfeld Credit Income Fund
HERZ
$31.6M
$222K 0.06%
4,871
-816
-14% -$36.4K
IDXX icon
141
Idexx Laboratories
IDXX
$46.2B
$215K 0.06%
440
EDIV icon
142
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.23B
$213K 0.06%
7,098
-1,978
-22% -$57.6K
ABBV icon
143
AbbVie
ABBV
$435B
$211K 0.06%
+1,953
New +$209K
GILD icon
144
Gilead Sciences
GILD
$165B
$211K 0.06%
+3,266
New +$211K
BIIB icon
145
Biogen
BIIB
$30.7B
$208K 0.06%
+744
New +$201K
THC icon
146
Tenet Healthcare
THC
$21.1B
$208K 0.06%
+4,000
New +$202K
LLY icon
147
Eli Lilly
LLY
$1.06T
$207K 0.06%
1,110
-80
-7% -$15.6K
NVS icon
148
Novartis
NVS
$297B
$207K 0.06%
2,416
-1,706
-41% -$153K
INCY icon
149
Incyte
INCY
$24.4B
$204K 0.06%
2,506
MCK icon
150
McKesson
MCK
$101B
$201K 0.06%
+1,029
New +$188K

Similar funds

Twin Focus Capital Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Twin Focus Capital Partners held 178 positions worth $350M, up 7.1% from $326M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Twin Focus Capital Partners's Q1 2021 filing shows 15 new, 51 increased, 33 reduced and 17 closed positions. Its largest new stake was Adverum Biotechnologies: 10,000 shares worth $986K. The largest sale was Enterprise Products Partners, an estimated $3.92M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 6.2% a quarter earlier, followed by Technology and Healthcare.

  • Twin Focus Capital Partners's largest Q1 2021 buy was Adverum Biotechnologies: 10,000 shares worth $986K.
  • Twin Focus Capital Partners added most to iShares Russell Mid-Cap Value ETF in Q1 2021, an estimated $2.79M increase.
  • Twin Focus Capital Partners's biggest Q1 2021 reduction was iShares Morningstar Growth ETF, cutting an estimated $907K.
  • Twin Focus Capital Partners fully exited Enterprise Products Partners in Q1 2021, selling an estimated $3.92M.
  • Twin Focus Capital Partners's ten largest holdings make up 47% of its $350M portfolio in Q1 2021.
  • Twin Focus Capital Partners opened 15 new positions and closed 17 in Q1 2021.
  • Twin Focus Capital Partners's portfolio value rose 7.1% quarter-over-quarter to $350M.

Based on Twin Focus Capital Partners's 13F filing for Q1 2021, filed 12 May 2021.